A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-small cell lung cancer
===========================================================================================================================================================================================================================

* Jan Baughman
* Deryk Loo
* Francine Chen
* Paul Moore
* Ezio Bonvini
* James Vasselli
* Jon Wigginton
* Roger Cohen